Synthace Team
Building a lab of the future? You're not alone. UCL selects Synthace to help them bridge the gap between digital and physical spaces.
Synthace and IDBS have entered a strategic partnership to provide state-of-the-art data foundations for experimentation in HTPD
Horizons Ventures and Sofinnova Partners Co-Lead Investment in Market-leading Life Sciences Software Company That Transforms the Way Scientists Autom
First ever no-code platform lowers barriers to automated biological experimentation and insight sharing.
Ming Liu
Our Visual Design Lead, Ming Liu, shares some insights into redesigning a product for a new company and how this works in biotech.
Synthace hires Guy Levy-Yurista as Chief Executive Officer.
Strong financial performance and achievement of other key milestones demonstrate the growing strength of Synthace’s offering within biopharma/biotech.
Dr. Jurascheck brings with him more than twenty years of experience spanning senior technology roles in high-tech product companies and consultancies.
Two European leaders in biopharma and integrative software are working together to advance drug discovery.
Synthace seeks to support the development and adoption of standards and FAIR (findable, accessible, interoperable and reusable) working practices.
